An Introduction to Health Economics

WHY YOU SHOULD ATTEND

It is vital that those involved in the clinical development and promotion of new drugs and technologies understand the discipline of health economics and, in particular, economic evaluation and the role it plays in determining access and coverage of new therapies. The objective of this course is to provide a thorough introduction to best practice in health economics. It will help you understand how to integrate economic studies into the development process and communicate appropriately to their customers.

WHO SHOULD ATTEND

This course is suitable for personnel working in Pharmaceutical and Medical Device Industries, who wish to gain an overview of health economics. It will be of particular relevance to medical directors, marketing directors, clinical research managers, business development managers, statisticians, data managers and regulatory affairs personnel, or anyone wanting an introduction to this important topic.

SPEAKERS:

• Professor Paul Trueman Professor of Health Economics and Director of the Health Economics Research Group, Brunel University, London
• Professor John Hutton Professor of Health Economics in the Department of Health Sciences at the University of York as well as a Project Director at YHEC

BENEFITS IN ATTENDING:

• Understand Economic Evaluation – Rationale and Policy Environment
• Discuss Methods of Economic Evaluation
• Discover Best Practice / Guidelines for Economic Evaluation
• How to Construct your Cost Effectiveness Evidence
• Understand Economic Evaluation in Practice
• Discuss Future Directions: Conditional Coverage, Risk Sharing and Patient Access Schemes